Importantly, in SMARCB1-null rhabdoid cancer cells, super-enhancers are both bound by remaining SWI/SNF subunits and are essential for rhabdoid tumor cell survival [11]. The gene discussed is SMARCB1; the disease is rhabdoid tumor.